- Home
- WIA vs CLYM Comparison
WIA vs CLYM Comparison
Compare WIA & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIA
- CLYM
- Stock Information
- Founded
- WIA 2003
- CLYM 2018
- Country
- WIA United States
- CLYM United States
- Employees
- WIA N/A
- CLYM N/A
- Industry
- WIA Trusts Except Educational Religious and Charitable
- CLYM
- Sector
- WIA Finance
- CLYM
- Exchange
- WIA Nasdaq
- CLYM NYSE
- Market Cap
- WIA 186.8M
- CLYM 201.7M
- IPO Year
- WIA N/A
- CLYM 2021
- Fundamental
- Price
- WIA $8.09
- CLYM $1.88
- Analyst Decision
- WIA
- CLYM
- Analyst Count
- WIA 0
- CLYM 0
- Target Price
- WIA N/A
- CLYM N/A
- AVG Volume (30 Days)
- WIA 39.2K
- CLYM 668.0K
- Earning Date
- WIA 01-01-0001
- CLYM 11-12-2024
- Dividend Yield
- WIA 12.29%
- CLYM N/A
- EPS Growth
- WIA N/A
- CLYM N/A
- EPS
- WIA N/A
- CLYM N/A
- Revenue
- WIA N/A
- CLYM N/A
- Revenue This Year
- WIA N/A
- CLYM N/A
- Revenue Next Year
- WIA N/A
- CLYM N/A
- P/E Ratio
- WIA N/A
- CLYM N/A
- Revenue Growth
- WIA N/A
- CLYM N/A
- 52 Week Low
- WIA $7.56
- CLYM $1.73
- 52 Week High
- WIA $8.91
- CLYM $11.55
- Technical
- Relative Strength Index (RSI)
- WIA 51.52
- CLYM N/A
- Support Level
- WIA $7.94
- CLYM N/A
- Resistance Level
- WIA $8.18
- CLYM N/A
- Average True Range (ATR)
- WIA 0.08
- CLYM 0.00
- MACD
- WIA 0.02
- CLYM 0.00
- Stochastic Oscillator
- WIA 65.20
- CLYM 0.00
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.